CATHERINE SMITH: Open Payments
NPI 1265171037 · AUGUSTA, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 5 payments from 5 companies in 2025. Trend: 2023 $133 · 2024 $118 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $134 |
| AstraZeneca Pharmaceuticals LP | 1 | $34 |
| Genentech USA, Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: Padcev, LYNPARZA, Itovebi, Fabhalta, OPDIVO.
Industry payments across ME — which companies pay providers there.
